ReportWire

Tag: flu season

  • Flu activity is low, but experts worry about a new strain and vaccination rates

    By MIKE STOBBE and NICKY FORSTER

    NEW YORK (AP) — The U.S. flu season is starting slowly, and it’s unclear if it will be as bad as last winter’s, but some health experts are worried as U.S. Centers for Disease Control and Prevention data posted Friday shows a new version of the virus has emerged.

    The Associated Press

    Source link

  • A new virus variant and lagging vaccinations may mean the US is in for a severe flu season

    The United States may be heading into its second severe flu season in a row, driven by a mutated strain called subclade K that’s behind early surges in the United Kingdom, Canada and Japan.Last winter’s season was extreme, too. The U.S. had its highest rates of flu hospitalizations in nearly 15 years. At least 280 children died of influenza, the highest number since pediatric death numbers were required to be shared in 2004.Now, with a new variant in the mix, experts say we’re on track for a repeat. And with flu vaccinations down and holiday travel on the way, they worry that things may look much worse in the weeks ahead.The good news: Early analysis shows that this season’s flu shots offer some protection against being hospitalized with this variant, especially for kids. The bad news is that many Americans appear to be skipping their flu vaccines this year. New data from prescription data company IQVIA shows that vaccinations are down compared to where they usually are at this point in the year.A new playerFlu activity is low but rising quickly in the United States, according to the latest FluView report from the U.S. Centers for Disease Control and Prevention.Most of the flu viruses identified this season have been an A strain called H3N2, and half of those have come from subclade K, a variant that was responsible for a rougher-than-normal flu season this summer in the Southern Hemisphere.That variant wasn’t a major player when scientists decided which strains should be in the annual flu shots, so the vaccines cover a related but slightly different group of viruses.”It’s not like we’re expecting to get complete loss of protection for the vaccine, but perhaps we might expect a little bit of a drop-off if this is the virus that sort of dominates the season, and early indications are that’s probably going to be the case,” said Dr. Richard Webby, director of the World Health Organization Collaborating Center for studies on the ecology of influenza in animals and birds at St. Jude Children’s Research Hospital.Early analysis by the U.K. Health Security Agency shows that subclade K has seven gene changes on a key segment of the virus. Those mutations change the shape of this region, making it harder for the body’s defenses to recognize.”That’s the predominant thing that our immune system targets with antibodies, and that’s also pretty much what’s in the vaccine,” said Dr. Adam Lauring, chief of the Division of Infectious Diseases at the University of Michigan Medical School.UKHSA scientists found that the current flu vaccines are still providing decent protection against subclade K viruses. Vaccination cut the odds of an emergency department visit or hospitalization for the flu by almost 75% in children. The effectiveness for adults, even those over 65, was lower, about 30% to 40% against needing to visit the hospital or ER.But the scientists offer a caveat: These results are from early in the season, before the protection from seasonal flu vaccines has had time to wane or wear off. The findings are posted in a recent preprint study, which means it was published ahead of scrutiny from outside experts.Still, some protection is better than no protection, and while subclade K is expected to dominate the season, it won’t be the only flu strain circulating. No one gets to pick what they’re exposed to. Lauring said his daughter has just recovered from the flu, but it was a B-type strain.At the same time this new variant has emerged, flu vaccinations appear to be down in the U.S. According to IQVIA, about 64% of all flu vaccinations were administered at retail pharmacies, which administered roughly 26.5 million flu shots between August and the end of October. That’s more than 2 million fewer shots than the 28.7 million given over the same time frame in 2024.”I’m not surprised,” said Dr. Jennifer Nuzzo, who directs the Pandemic Center at Brown University’s School of Public Health. Vaccine skepticism expressed by leaders of the US Department of Health and Human Services has “injected chaos into the whole vaccination system,” she said.”There’s been a lot of attention on really non-issues,” like vaccine ingredients and separating shots, that she thinks “at the best, left people confused but possibly at the worst have left people worried about getting vaccinated,” she added.Flu vaccinations have also fallen in Australia, where subclade K was the predominant virus this year. As a result, flu hit a record, with more than 443,000 cases. Flu season in the Southern Hemisphere typically runs from May to July, so infectious disease experts often look to those countries for a preview of what might be on the way to North America.”What they saw in Australia is that they had a bad season. And so it’s concerning for you and us, what’s coming,” said Dr. Earl Rubin, director of the infectious disease division at the Montreal Children’s Hospital in Canada.’This is the time we start to see the rise’It’s difficult to say whether subclade K actually makes a person sicker than other flu strains, but if it drives more cases, it will certainly drive hospitalizations too, Rubin said.”When you look at severity, the more cases you have, if the same percentage get hospitalized, obviously you’re going to have more hospitalization if you have more cases. So it sometimes will look like the severity is also worse,” he said.Lab testing data has begun to show an uptick in flu cases.”This is the time we start to see the rise,” said Dr. Allison McMullen, a clinical microbiologist at BioMerieux, which makes the BioFire test, a popular diagnostic tool for respiratory pathogens.The company anonymously compiles its test results into a syndromic surveillance tool, which can offer a glimpse of what bugs are making people sick at any given time. At the beginning of the month, less than 1% of tests were positive for type A flu. Now it’s 2.4% – still low numbers but going up briskly, which aligns with the CDC trend.”We’re going to start seeing heavy holiday travel before we know it,” McMullen added. “With the rising cases that we’re seeing the U.K. and Japan, it can definitely be a bellwether for what we’re going to see in North America.”Signals are also rising in wastewater, said Dr. Marlene Wolfe, an assistant professor of environmental health at Emory University. In October, 18% of samples in the WastewaterSCAN network — an academically led wastewater monitoring program based at Stanford University, in partnership with Emory — were positive for type A flu, Wolfe said. In November, that number had risen to 40%.”Flu is something where, when it’s not in season, we don’t detect it very frequently in wastewater,” Wolfe said. COVID, on the other hand, can be detected pretty much all the time, which makes it challenging to know if it’s going up or down, she said.The scientists can set a threshold for when they can declare that a specific area is in flu season, Wolfe says. So far, just four of the 147 sites they monitor in 40 states have reached that threshold. Those sites are in the Northeast — in Maine and Vermont — in Iowa and in Hawaii.”I am concerned, I guess, that we could have a big flu season this year based on what we’re seeing in other parts of the world, and particularly Europe and elsewhere,” Michigan’s Lauring said.”It’s not too late. Go and get your flu shot,” Lauring advised. “And be alert that it’s out there.”

    The United States may be heading into its second severe flu season in a row, driven by a mutated strain called subclade K that’s behind early surges in the United Kingdom, Canada and Japan.

    Last winter’s season was extreme, too. The U.S. had its highest rates of flu hospitalizations in nearly 15 years. At least 280 children died of influenza, the highest number since pediatric death numbers were required to be shared in 2004.

    Now, with a new variant in the mix, experts say we’re on track for a repeat. And with flu vaccinations down and holiday travel on the way, they worry that things may look much worse in the weeks ahead.

    The good news: Early analysis shows that this season’s flu shots offer some protection against being hospitalized with this variant, especially for kids. The bad news is that many Americans appear to be skipping their flu vaccines this year. New data from prescription data company IQVIA shows that vaccinations are down compared to where they usually are at this point in the year.

    A new player

    Flu activity is low but rising quickly in the United States, according to the latest FluView report from the U.S. Centers for Disease Control and Prevention.

    Most of the flu viruses identified this season have been an A strain called H3N2, and half of those have come from subclade K, a variant that was responsible for a rougher-than-normal flu season this summer in the Southern Hemisphere.

    That variant wasn’t a major player when scientists decided which strains should be in the annual flu shots, so the vaccines cover a related but slightly different group of viruses.

    “It’s not like we’re expecting to get complete loss of protection for the vaccine, but perhaps we might expect a little bit of a drop-off if this is the virus that sort of dominates the season, and early indications are that’s probably going to be the case,” said Dr. Richard Webby, director of the World Health Organization Collaborating Center for studies on the ecology of influenza in animals and birds at St. Jude Children’s Research Hospital.

    Early analysis by the U.K. Health Security Agency shows that subclade K has seven gene changes on a key segment of the virus. Those mutations change the shape of this region, making it harder for the body’s defenses to recognize.

    “That’s the predominant thing that our immune system targets with antibodies, and that’s also pretty much what’s in the vaccine,” said Dr. Adam Lauring, chief of the Division of Infectious Diseases at the University of Michigan Medical School.

    UKHSA scientists found that the current flu vaccines are still providing decent protection against subclade K viruses. Vaccination cut the odds of an emergency department visit or hospitalization for the flu by almost 75% in children. The effectiveness for adults, even those over 65, was lower, about 30% to 40% against needing to visit the hospital or ER.

    But the scientists offer a caveat: These results are from early in the season, before the protection from seasonal flu vaccines has had time to wane or wear off. The findings are posted in a recent preprint study, which means it was published ahead of scrutiny from outside experts.

    Still, some protection is better than no protection, and while subclade K is expected to dominate the season, it won’t be the only flu strain circulating. No one gets to pick what they’re exposed to. Lauring said his daughter has just recovered from the flu, but it was a B-type strain.

    At the same time this new variant has emerged, flu vaccinations appear to be down in the U.S. According to IQVIA, about 64% of all flu vaccinations were administered at retail pharmacies, which administered roughly 26.5 million flu shots between August and the end of October. That’s more than 2 million fewer shots than the 28.7 million given over the same time frame in 2024.

    “I’m not surprised,” said Dr. Jennifer Nuzzo, who directs the Pandemic Center at Brown University’s School of Public Health. Vaccine skepticism expressed by leaders of the US Department of Health and Human Services has “injected chaos into the whole vaccination system,” she said.

    “There’s been a lot of attention on really non-issues,” like vaccine ingredients and separating shots, that she thinks “at the best, left people confused but possibly at the worst have left people worried about getting vaccinated,” she added.

    Flu vaccinations have also fallen in Australia, where subclade K was the predominant virus this year. As a result, flu hit a record, with more than 443,000 cases. Flu season in the Southern Hemisphere typically runs from May to July, so infectious disease experts often look to those countries for a preview of what might be on the way to North America.

    “What they saw in Australia is that they had a bad season. And so it’s concerning for you and us, what’s coming,” said Dr. Earl Rubin, director of the infectious disease division at the Montreal Children’s Hospital in Canada.

    ‘This is the time we start to see the rise’

    It’s difficult to say whether subclade K actually makes a person sicker than other flu strains, but if it drives more cases, it will certainly drive hospitalizations too, Rubin said.

    “When you look at severity, the more cases you have, if the same percentage get hospitalized, obviously you’re going to have more hospitalization if you have more cases. So it sometimes will look like the severity is also worse,” he said.

    Lab testing data has begun to show an uptick in flu cases.

    “This is the time we start to see the rise,” said Dr. Allison McMullen, a clinical microbiologist at BioMerieux, which makes the BioFire test, a popular diagnostic tool for respiratory pathogens.

    The company anonymously compiles its test results into a syndromic surveillance tool, which can offer a glimpse of what bugs are making people sick at any given time. At the beginning of the month, less than 1% of tests were positive for type A flu. Now it’s 2.4% – still low numbers but going up briskly, which aligns with the CDC trend.

    “We’re going to start seeing heavy holiday travel before we know it,” McMullen added. “With the rising cases that we’re seeing the U.K. and Japan, it can definitely be a bellwether for what we’re going to see in North America.”

    Signals are also rising in wastewater, said Dr. Marlene Wolfe, an assistant professor of environmental health at Emory University. In October, 18% of samples in the WastewaterSCAN network — an academically led wastewater monitoring program based at Stanford University, in partnership with Emory — were positive for type A flu, Wolfe said. In November, that number had risen to 40%.

    “Flu is something where, when it’s not in season, we don’t detect it very frequently in wastewater,” Wolfe said. COVID, on the other hand, can be detected pretty much all the time, which makes it challenging to know if it’s going up or down, she said.

    The scientists can set a threshold for when they can declare that a specific area is in flu season, Wolfe says. So far, just four of the 147 sites they monitor in 40 states have reached that threshold. Those sites are in the Northeast — in Maine and Vermont — in Iowa and in Hawaii.

    “I am concerned, I guess, that we could have a big flu season this year based on what we’re seeing in other parts of the world, and particularly Europe and elsewhere,” Michigan’s Lauring said.

    “It’s not too late. Go and get your flu shot,” Lauring advised. “And be alert that it’s out there.”

    Source link

  • Missed your annual flu shot? Local doctor says: ‘Time to get it’ – WTOP News

    This year’s flu season may arrive later than usual, but that does not necessarily mean it will be mild. It does mean that it’s not too late to get your flu vaccine.

    There is no one-to-one correlation between cold weather and getting sick.

    That old adage about stepping outside and catching a cold does not tell the whole story. What does matter is that winter pushes people indoors and into closer contact, making it easier for viruses to spread.

    Children’s National Hospital infectious disease physician Dr. Alexandra Yonts told WTOP that this year’s flu season may arrive later than usual, but that doesn’t necessarily mean it will be mild.

    She warned flu cases could start climbing “after Christmas and New Year’s,” when people travel and families gather.

    “Last year, almost 300 children died from influenza, and most of (them) were previously healthy,” Yonts said.

    She said one reason the flu shot remains essential is for protecting people with respiratory illnesses, existing health conditions or weakened immune systems.

    And no, the flu shot cannot give you the flu.

    “In common vocabulary, we throw around the term ‘flu’ to mean any sort of viral illness that gives us a fever. But there are hosts of other viruses that are not covered by the influenza vaccine that can still make you sick,” she said. “Protecting you against influenza specifically is still a priority.”

    Yonts added that getting vaccinated is especially important before visiting young children, elderly relatives or immunocompromised family members during the holidays.

    “Think of it as doing it for those people, if you aren’t interested in doing it just for yourself,” she said.

    If you’re behind, Yonts said getting both the flu shot and the updated COVID booster at the same visit is completely safe: “That has been studied, and it shows there’s no major difference in the side effects. If anything, you’re getting them both out of the way at once.”

    Flu shots are recommended for those 6 months old and older, and doctors say it takes about two weeks to build full immunity.

    Get breaking news and daily headlines delivered to your email inbox by signing up here.

    © 2025 WTOP. All Rights Reserved. This website is not intended for users located within the European Economic Area.

    Abigail Constantino

    Source link

  • A new virus variant and lagging vaccinations may mean the US is in for a severe flu season

    (CNN) — The United States may be heading into its second severe flu season in a row, driven by a mutated strain called subclade K that’s behind early surges in the United Kingdom, Canada and Japan.

    Last winter’s season was extreme, too. The US had its highest rates of flu hospitalizations in nearly 15 years. At least 280 children died of influenza, the highest number since pediatric death numbers were required to be shared in 2004.

    Now, with a new variant in the mix, experts say we’re on track for a repeat. And with flu vaccinations down and holiday travel on the way, they worry that things may look much worse in the weeks ahead.

    The good news: Early analysis shows that this season’s flu shots offer some protection against being hospitalized with this variant, especially for kids. The bad news is that many Americans appear to be skipping their flu vaccines this year. New data from prescription data company IQVIA shows that vaccinations are down compared to where they usually are at this point in the year.

    A new player

    Flu activity is low but rising quickly in the United States, according to the latest FluView report from the US Centers for Disease Control and Prevention.

    Most of the flu viruses identified this season have been an A strain called H3N2, and half of those have come from subclade K, a variant that was responsible for a rougher-than-normal flu season this summer in the Southern Hemisphere.

    That variant wasn’t a major player when scientists decided which strains should be in the annual flu shots, so the vaccines cover a related but slightly different group of viruses.

    “It’s not like we’re expecting to get complete loss of protection for the vaccine, but perhaps we might expect a little bit of a drop-off if this is the virus that sort of dominates the season, and early indications are that’s probably going to be the case,” said Dr. Richard Webby, director of the World Health Organization Collaborating Center for studies on the ecology of influenza in animals and birds at St. Jude Children’s Research Hospital.

    Early analysis by the UK Health Security Agency shows that subclade K has seven gene changes on a key segment of the virus. Those mutations change the shape of this region, making it harder for the body’s defenses to recognize.

    “That’s the predominant thing that our immune system targets with antibodies, and that’s also pretty much what’s in the vaccine,” said Dr. Adam Lauring, chief of the Division of Infectious Diseases at the University of Michigan Medical School.

    UKHSA scientists found that the current flu vaccines are still providing decent protection against subclade K viruses. Vaccination cut the odds of an emergency department visit or hospitalization for the flu by almost 75% in children. The effectiveness for adults, even those over 65, was lower, about 30% to 40% against needing to visit the hospital or ER.

    But the scientists offer a caveat: These results are from early in the season, before the protection from seasonal flu vaccines has had time to wane or wear off. The findings are posted in a recent preprint study, which means it was published ahead of scrutiny from outside experts.

    Still, some protection is better than no protection, and while subclade K is expected to dominate the season, it won’t be the only flu strain circulating. No one gets to pick what they’re exposed to. Lauring said his daughter has just recovered from the flu, but it was a B-type strain.

    At the same time this new variant has emerged, flu vaccinations appear to be down in the US. According to IQVIA, about 64% of all flu vaccinations were administered at retail pharmacies, which administered roughly 26.5 million flu shots between August and the end of October. That’s more than 2 million fewer shots than the 28.7 million given over the same time frame in 2024.

    “I’m not surprised,” said Dr. Jennifer Nuzzo, who directs the Pandemic Center at Brown University’s School of Public Health. Vaccine skepticism expressed by leaders of the US Department of Health and Human Services has “injected chaos into the whole vaccination system,” she said.

    “There’s been a lot of attention on really non-issues,” like vaccine ingredients and separating shots, that “I think, at the best, left people confused but possibly at the worst have left people worried about getting vaccinated,” she added.

    Flu vaccinations have also fallen in Australia, where subclade K was the predominant virus this year. As a result, flu hit a record, with more than 443,000 cases. Flu season in the Southern Hemisphere typically runs from May to July, so infectious disease experts often look to those countries for a preview of what might be on the way to North America.

    “What they saw in Australia is that they had a bad season. And so it’s concerning for you and us, what’s coming,” said Dr. Earl Rubin, director of the infectious disease division at the Montreal Children’s Hospital in Canada.

    ‘This is the time we start to see the rise’

    It’s difficult to say whether subclade K actually makes a person sicker than other flu strains, but if it drives more cases, it will certainly drive hospitalizations too, Rubin said.

    “When you look at severity, the more cases you have, if the same percentage get hospitalized, obviously you’re going to have more hospitalization if you have more cases. So it sometimes will look like the severity is also worse,” he said.

    Lab testing data has begun to show an uptick in flu cases.

    “This is the time we start to see the rise,” said Dr. Allison McMullen, a clinical microbiologist at BioMerieux, which makes the BioFire test, a popular diagnostic tool for respiratory pathogens.

    The company anonymously compiles its test results into a syndromic surveillance tool, which can offer a glimpse of what bugs are making people sick at any given time. At the beginning of the month, less than 1% of tests were positive for type A flu. Now it’s 2.4% – still low numbers but going up briskly, which aligns with the CDC trend.

    “We’re going to start seeing heavy holiday travel before we know it,” McMullen added. “With the rising cases that we’re seeing the UK and Japan, it can definitely be a bellwether for what we’re going to see in North America.”

    Signals are also rising in wastewater, said Dr. Marlene Wolfe, an assistant professor of environmental health at Emory University. In October, 18% of samples in the WastewaterSCAN network – an academically led wastewater monitoring program based at Stanford University, in partnership with Emory – were positive for type A flu, Wolfe said. In November, that number had risen to 40%.

    “Flu is something where, when it’s not in season, we don’t detect it very frequently in wastewater,” Wolfe said. Covid, on the other hand, can be detected pretty much all the time, which makes it challenging to know if it’s going up or down, she said.

    The scientists can set a threshold for when they can declare that a specific area is in flu season, Wolfe says. So far, just four of the 147 sites they monitor in 40 states have reached that threshold. Those sites are in the Northeast – in Maine and Vermont – in Iowa and in Hawaii.

    “I am concerned, I guess, that we could have a big flu season this year based on what we’re seeing in other parts of the world, and particularly Europe and elsewhere,” Michigan’s Lauring said.

    “It’s not too late. Go and get your flu shot,” Lauring advised. “And be alert that it’s out there.”

    Brenda Goodman and CNN

    Source link

  • Should kids get flu and COVID shots this fall? Here’s what to know as some vaccine guidance shifts.

    As the fall respiratory season approaches and differing recommendations for children’s COVID-19 and flu shots cause confusion, who should be getting vaccinated to protect against illness?

    Earlier this month, the Centers for Disease Control and Prevention’s vaccine advisory committee, known as the Advisory Committee on Immunization Practices, or ACIP, voted to change recommendations for the COVID-19 vaccine. 

    The ACIP’s recommendations are not the final say — they must be reviewed and approved by the CDC director to become official guidance. But CDC directors have almost always accepted the recommendations.

    Here’s where recommendations currently stand.  

    Flu shots

    Guidance on the flu shot for kids is consistent across top medical groups: Children 6 months and older are generally advised to get the shot. 

    The CDC recommends that everyone 6 months and older get a flu vaccine every season, with rare exceptions.

    The American Academy of Pediatrics (AAP) also recommends that everyone 6 months and older without medical contradictions get vaccinated. 

    For pregnant women, flu shots — specifically the injection, not the nasal spray — are also recommended by both the CDC and AAP.

    Protecting kids from the flu is important because infections can lead to hospitalizations and sometimes be deadly, the CDC says. During the 2023-24 flu season, for example, the CDC reported nearly 200 flu-related deaths among children in the U.S. Most of them were eligible for a vaccine but were not fully vaccinated, the CDC said.

    Flu season typically starts in December and peaks in February, so the optimal time to get vaccinated is heading into the season, 
    doctors say. It takes about 2 weeks for protection to develop after vaccination.

    COVID vaccine

    For the COVID-19 vaccine, advice currently varies. 

    The CDC says parents of healthy children ages 6 months to 17 years old should discuss the benefits with a health care provider and “may receive” it, but the agency stops short of recommending the shot. The agency broadly recommends COVID-19 vaccines for moderately or severely immunocompromised children.

    The American Academy of Pediatrics, however, recently shared vaccine recommendations that, for the first time in three decades, differ from U.S. government advice. In the guidance, the AAP is “strongly recommending” COVID-19 shots for children ages 6 months to 2 years old. For older children, shots are also advised but it’s up to parents’ discretion, the AAP said.

    Other top medical groups have also shared recommendations differing from the CDC’s advice. 

    For example, the Infectious Diseases Society of America, a medical association representing physicians and scientists who specialize in infectious diseases, recommends the COVID-19 vaccine for everyone ages 6 months and older.

    And a group of four West Coast states has joined together to issue recommendations on COVID-19 shots and other vaccines that differ from CDC guidance. The West Coast Health Alliance recommends the COVID vaccine for all children 6 months to 23 months old and those 2 to 18 years old with risk factors or who have never been vaccinated.

    The announcement was made last week in a joint statement from Oregon Gov. Tina Kotek, Washington Gov. Bob Ferguson, California Gov. Gavin Newsom and Hawaii Gov. Josh Green, all Democrats, saying they were putting safety before politics.

    In the Northeast, New York and its neighbors created the Northeast Public Health Collaborative, with Gov. Kathy Hochul calling it a rebuke to Washington’s retreat from science. The voluntary coalition includes New York state, New York City, Connecticut, Maine, Massachusetts, New Jersey, Pennsylvania and Rhode Island.

    “Every resident will have access to the COVID vaccine, no exceptions,” Hochul said in a statement, which advises vaccinations for children 6 months to 18 years old.

    CDC advisory panel’s proposed COVID changes

    The CDC’s advisory committee, the ACIP, has undergone changes in recent months, with all new members picked by Health and Human Services Secretary Robert F. Kennedy Jr., who is known for raising doubts about vaccines.

    In their latest meeting, the ACIP voted for people to make individual, informed decisions about COVID vaccination, and it declined to specifically recommend COVID vaccination. This is a change from current guidance, since it drops recommendations for even children at high risk.

    The updated recommendations, which are not yet considered official but are expected to be soon, would include the following for children:

    • Individuals 6 months to 64 years: Vaccination based on individual-based decision-making — with an emphasis that the risk-benefit of vaccination is most favorable for individuals who are at an increased risk for severe COVID-19 disease and lowest for individuals who are not at an increased risk, according to the CDC list of COVID-19 risk factors.

    Dr. Paul Offit — a vaccine researcher at Children’s Hospital of Philadelphia and a former government adviser who has sparred with Kennedy for years — said that with this proposed change, “the good news is anyone can get the vaccine.” But “the bad news is that no one is encouraged to get it even if you’re in a high-risk group,” he recently told The Associated Press.

    Varying advice has already caused confusion for parents.

    Dr. Amesh Adalja, a senior scholar at Johns Hopkins Center for Health Security, said he expects confusion around the COVID vaccine due to the panel’s recent vote. 

    “What I think it means is that people are going to be uncertain whether or not the COVID-19 vaccine is a benefit to them,” he told CBS News on Friday

    Dr. Céline Gounder, CBS News medical contributor and editor-at-large for public health at KFF Health News, says there’s “a lot of noise out there” when it comes to vaccines, but advises parents to “stick the course” and talk to your doctor about making sure children get all their necessary vaccinations.

    Source link

  • FDA approves first self-administered flu vaccine spray

    FDA approves first self-administered flu vaccine spray

    The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first “self-administered” influenza vaccine — though a delay in the change means the vaccine will not be available to ship to homes until next year’s flu season at the earliest.

    “Today’s approval of the first influenza vaccine for self- or caregiver-administration provides a new option for receiving a safe and effective seasonal influenza vaccine potentially with greater convenience, flexibility and accessibility,” Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in a statement.

    The FluMist vaccine, manufactured by AstraZeneca, had previously been approved back in 2003 to be given by health care providers similar to other flu shots. Now the vaccinemaker has approval to sell FluMist to adults for use at home on themselves or to administer to their children. 

    The FDA says patients will still need to get a prescription for the vaccine from a health care provider. 

    AstraZeneca says it plans to sell FluMist directly to patients through an online pharmacy. Adults will be able to complete a screening questionnaire to get the prescription, and then order shipments to their home.

    There are also some limits to the kinds of people FluMist is recommended for. Since it uses a live but weakened version of the virus, some patients, like pregnant people or those who are severely immunocompromised, should not get this vaccine.

    flumist3.jpg
    The FDA approved AstraZeneca’s FluMist flu vaccine spray for self-administered use at home.

    AstraZeneca


    FluMist is less commonly used these days by pharmacies and doctors, in part due to fallout from a Centers for Disease Control and Prevention recommendation in 2016 against use of the spray over “poor or relatively lower effectiveness” compared to other vaccines.

    AstraZeneca later redesigned the antigens in the vaccine, earning back the CDC’s recommendation starting in 2018

    Since then, the CDC says it has not had enough data for new official effectiveness estimates comparing FluMist to other flu vaccines, “because of limited use” in the U.S.

    But AstraZeneca has cited data showing the shot has had “comparable” effectiveness in Europe versus more widely used shots.

    AstraZeneca had initially told investors it hoped the FDA would broaden approval in time for this flu season, after the company submitted data last year showing that adults were able to correctly follow instructions to administer the vaccine spray on their own.

    AstraZeneca did not comment when asked why the FDA’s approval decision came later than the company previously said it expected.

    “We’re working diligently to bring this ‘first-of-its-kind’ innovative and convenient self-administrated flu vaccine to consumers and look forward to launching FluMist Home as soon as next flu season,” a spokesperson for the company said in a statement.

    The spokesperson said AstraZeneca needed time to work with its partners to “ensure a seamless customer experience” for FluMist’s rollout for home use.

    Source link

  • Mpox

    Mpox

    Geneva — The mpox outbreak is not another COVID-19, the World Health Organization said Tuesday, because much is already known about the virus and the means to control it. While more research is needed on the Clade 1b strain which prompted the United Nations agency to declare a public health emergency of international concern (PHEIC), the spread of mpox can be reined in, the WHO’s European director Hans Kluge said.

    In July 2022, the WHO declared a PHEIC over the international outbreak of the less severe Clade 2b strain of mpox, which mostly affected gay and bisexual men. The alarm was lifted in May 2023.

    “Mpox is not the new COVID,” Kluge insisted. “We know how to control mpox and, in the European region, the steps needed to eliminate its transmission altogether,” he told a media briefing in Geneva, via video-link.

    “Two years ago, we controlled mpox in Europe thanks to the direct engagement with the most affected communities,” he said. We put in place robust surveillance; we thoroughly investigated new cases contacts; and we provided sound public health advice. Behavior change, non-discriminatory public health action, and mpox vaccination contributed to controlling the outbreak.”


    Advocates use end of Pride Month to warn about mpox

    02:42

    Kluge said the risk to the general population from the virus was low.

    “Are we going to go in lockdown in the WHO European region, [as if] it’s another COVID-19? The answer is clearly no,” he said.

    Kluge said the predominant route of transmission remained close skin-to-skin contact, but he said it was possible that someone in the acute phase of mpox infection, especially with blisters in the mouth, could transmit the virus to close contacts by droplets, in circumstances such as in the home or in hospitals.

    “The modes of transmission are still a bit unclear. More research is required,” he said.

    WHO spokesman Tarik Jasarevic said the agency was not recommending the use of masks.

    “We are not recommending mass vaccination. We are recommending to use vaccines in outbreak settings for the groups who are most at risk,” he added.

    Mpox surge in Central Africa exposes awareness gap
    Internally displaced women listen to Nathalie Kipenzi, a hygiene promoter, during an awareness campaign for mpox, an infectious disease that causes a painful rash, enlarged lymph nodes and fever, at the Muja camp for the internally displaced in Nyiragongo territory, near Goma in North Kivu province, Democratic Republic of Congo, Aug. 19, 2024.

    Arlette Bashizi/REUTERS


    The WHO declared an international health emergency on August 14, concerned by the rise in cases of Clade 1b in the Democratic Republic of Congo and its spread to nearby countries.

    The WHO declaration came after the Africa Centers for Disease Control and Prevention declared the outbreaks of mpox (formerly known as monkeypox) a public health emergency, with more than 500 deaths attributed to the disease, and called for international help to stop it spreading.

    “This is something that should concern us all,” WHO director-general Tedros Adhanom Ghebreyesus said at the time. “The potential for further spread within Africa and beyond is very worrying.”

    Source link

  • Flu cases in some Southern states on the rise, bucking national trend

    Flu cases in some Southern states on the rise, bucking national trend

    Flu cases in some Southern states on the rise, bucking national trend – CBS News


    Watch CBS News



    Nationally, the number of flu cases has decreased. But in some Southern states, flu activity is still high, including in Dallas County, Texas, where almost 20% of tests are positive. Omar Villafranca reports.

    Be the first to know

    Get browser notifications for breaking news, live events, and exclusive reporting.


    Source link

  • How to identify severe flu symptoms in children

    How to identify severe flu symptoms in children

    How to identify severe flu symptoms in children – CBS News


    Watch CBS News



    Flu cases are surging nationwide and 27 children are among those who have died this flu season. One hospital shares ways to be on the lookout for respiratory issues. Janet Shamlian reports.

    Be the first to know

    Get browser notifications for breaking news, live events, and exclusive reporting.


    Source link

  • Riverside County confirms first 2 flu-related deaths this season; L.A. County has reported 1 so far

    Riverside County confirms first 2 flu-related deaths this season; L.A. County has reported 1 so far

    With flu season in full swing, Riverside County public health officials are urging residents to get their vaccines and to take other precautions against respiratory viruses after reporting the county’s first two flu-related deaths this winter.

    The deaths include a 73-year-old man and a 79-year-old woman from mid- and western Riverside County, respectively. Both had underlying health issues and died at local hospitals, according to county officials. No further information was immediately provided.

    Last month, Los Angeles County confirmed its first flu death of the season. The deceased was an elderly resident with multiple underlying conditions and had no record of influenza vaccination this season, according to county health officials.

    According to Riverside County’s weekly influenza surveillance report, current influenza-like illnesses activity levels are moderate in the area. The county typically logs people aged 65 and older as the bulk of pneumonia and influenza deaths in the county with few occurring among those 24 and younger. Data collected between Nov. 19-25 show pneumonia contributed to the bulk of deaths, which were largely affected by other diseases such as COVID-19.

    “These tragedies remind us that influenza can be serious, especially for those who have health issues or weakened immune systems,” Dr. Geoffrey Leung, public health officer for Riverside County, said in a statement. “There are simple steps that can be taken to protect ourselves. Most important of these is to get vaccinated. We recommend that everyone over 6 months of age receive the flu vaccine.”

    Respiratory viruses such as the flu and COVID-19 spread year-round but are more common in the United States between October and March. The virus is spread through coughing and sneezing. Anyone is prone to catch the virus but elderly people, children and those with weakened immune systems are more at risk.

    Health officials urge people to stay up-to-date on vaccines, remain at home if sick, consider wearing a face mask, cover a cough or sneeze and wash hands throughout the day.

    Priscella Vega

    Source link

  • Do You Have the Flu, RSV, COVID, or the Common Cold?

    Do You Have the Flu, RSV, COVID, or the Common Cold?

    Winter is almost here, and with it may come runny noses, coughing, and congestion. But how do you know if you just have a common cold, or if you have one or more of the three respiratory viruses that make up the “tripledemic” – RSV (respiratory syncytial virus), COVID-19, and influenza?

    Source link

  • How FDA’s top vaccines official is timing his COVID booster and flu shot for fall 2023

    How FDA’s top vaccines official is timing his COVID booster and flu shot for fall 2023

    A top-ranking Food and Drug Administration official, responsible for overseeing the approvals of the new vaccines now rolling out for this fall and winter’s three respiratory virus threats, said this month he is personally planning to space out his vaccinations over the coming weeks. 

    “Some people are saying, ‘Well, could I get RSV, COVID and the flu vaccine on the same day?’ Yes, indeed, you could. But honestly, I might not,” said Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research. 

    Instead, he said he intended to get the COVID shot right away and the flu shot in early October.

    Marks, who was speaking during a recent call with FDA stakeholders, stressed that he did not disagree with guidance from the Centers for Disease Control and Prevention which allows giving multiple different routine shots during the same visit. Doctors refer to this as “coadministration” or “simultaneous administration” of vaccines.

    However, he acknowledged that getting up to three of the different vaccines at the same time could lead to more side effects — like stronger fatigue or a small fever — in the days after getting the shots. 

    Spacing out the shots by around two weeks could “minimize the chance of interactions, and minimize confusing side effects from one with another,” he said. They might be a good option for people who did not mind multiple trips to the pharmacy or their doctor’s office.

    “I might just want to space them out a little bit. But if you had to drive a lot of miles to get the vaccines, then it might not be unreasonable to get all three of them at once,” said Marks.

    Getting an updated COVID-19 vaccine now

    Of the currently available options, Marks said that his plan was to get a dose of the updated COVID-19 vaccine first.

    Health authorities have been fortunate to have a vaccine that appears likely to work well for protecting against the currently circulating strains of the virus, he said.

    “It’s like having a bird in the hand. I have a bird in the hand, good match, a lot of COVID around, great time to go get vaccinated,” said Marks. 

    The FDA had selected the strain to target in the current batch of shots back in June, clearing the way for vaccine makers to ramp up their production ahead of a fall rollout. 

    Marks cited recent data suggesting that these updated vaccines, which have been revised from previous designs to now target the XBB.1.5 strain of the virus, would also work to boost protection against its closely-related descendants now dominant nationwide.

    Early results shared by the vaccine makers with a CDC panel earlier this month also suggests that these updated shots will also work against the highly mutated BA.2.86 variant, which has been reported in a growing number of states. 

    Several leading COVID trends, like emergency department visits, have started to slow in recent weeks following a summer wave that began to accelerate last month. Another “moderate” wave is predicted to begin over the coming colder months, the CDC’s disease forecasters say, with that surge’s peak expected to arrive potentially earlier than it did last season.

    Marks said it was possible that health authorities might allow for another dose to be offered to some vulnerable groups later in the fall and winter. 

    “I think if we saw that it appeared that people might benefit in a few months from an additional dose, we would probably work with our CDC colleagues to issue a recommendation at that time. But right now we are just talking about a single recommendation, a single dose,” he said.

    Scheduling a flu shot for early October

    By early next month, Marks said he plans to have received his flu shot. 

    “I usually get my influenza vaccine around October 1st,” Marks said. 

    This is later than some other health officials within the Biden administration. CDC Director Dr. Mandy Cohen posted on social media on Sept. 6 to say she had gotten vaccinated for the flu.

    Similar to previous seasons, CDC’s official recommendations for this year are that “[flu] vaccination should ideally be offered during September or October.” 

    Marks said that the boost in protection offered by flu vaccines can wane, underscoring why the shots should not be given too early in the season, before the threat of infections ramps up. Flu season in the U.S. typically peaks between December and February, but can stretch into the spring.

    The protection from a flu shot “has a little bit of a shorter life than we might like, in some ways it’s a little like the COVID vaccines,” Marks said.

    Right now, weekly CDC data suggests flu activity remains at low levels in most parts of the country. 

    New options for RSV

    Some Americans also have new options to be immunized for RSV, or respiratory syncytial virus, for the first time this year. 

    Older adults, ages 60 and older, can get a dose of the new vaccines developed by Pfizer or GSK. The CDC recommends that shots be offered “as early as vaccine supply becomes available” this year.

    CDC data suggests RSV infections have begun to accelerate in some parts of the country, with the steepest rises in the Southeast. 

    A panel of CDC advisers on Friday recommended that Pfizer’s new RSV vaccine should be given during pregnancy as well, in hopes of passing on protection to newborns during their most vulnerable early months of life. The panel recommended that pregnant people take one dose of the vaccine between weeks 32 and 36 of pregnancy. 

    A new antibody injection from Sanofi and AstraZeneca is also available for babies this year, which is recommended to be given to infants born ahead of this coming RSV season.

    Source link

  • Flu Season Ends Not With a Bang but a Whimper

    Flu Season Ends Not With a Bang but a Whimper

    March 10, 2023 – The 2022-23 flu season lingered through the second half of January and most of February at the edge of its defined existence, but it now appears to be over.

    For the CDC, the annual epidemic known as flu season “occurs when flu activity is higher than a CDC-defined ‘baseline’ value.” That value, expressed as the proportion of all outpatient visits involving influenza-like illness to health care providers in the U.S. Outpatient ILI Surveillance Network, is currently 2.5%.

    Over the last 6 weeks, the national figure has been between 2.6% (Feb. 19-25), and 2.7% (Jan. 15-21). In other words, it has lingered like no flu season has lingered before, at least not since the CDC began setting a national baseline in 2007-08.

    But for the week of Feb. 26 to March 4, outpatient flu-like illness visits represented just 2.4% of all visits, the CDC’s Influenza Division reported, dropping under the baseline for the first time since the first week of October 2022.

    Back then, the early start to the flu season raised concern about a “tripledemic” involving respiratory syncytial virus (RSV) and COVID-19. But by the time the flu season peaked, RSV activity had already started declining and the expected COVID surge never occurred, CDC data shows.

    Since the start of the 2022-23 season, the United States has had at least 26 million flu illnesses, 290,000 hospitalizations, and 18,000 deaths, 125 of which were child deaths, the CDC estimates.

     

    Source link

  • This season’s flu vaccine provided “substantial protection” across all age groups, CDC says

    This season’s flu vaccine provided “substantial protection” across all age groups, CDC says

    The flu shot provided “substantial protection” for all age groups, including elderly and immunocompromised populations, during this influenza season, the Center for Disease Control reported Wednesday.

    The Advisory Committee on Immunization Practices presented new findings that showed people who received the influenza vaccination were well protected from “inpatient, emergency department, and outpatient illness among all ages” in the 2022-2023 season. 

    It also reduced the chance of hospitalization from Influenza A — the virus that causes flu pandemics — in children by nearly three-quarters, and in adults by nearly half, the CDC said in a press release.

    “These data underscore that flu vaccination can offer substantial benefit against flu and its potentially serious complications,” the agency said.

    One of the referenced studies in the presentation determined that the influenza vaccine was 45% effective among children against the predominant virus. In comparison, during previous seasons, this rate has been about 30%, the CDC wrote.

    Additionally, vaccinated children were 68% less likely to be hospitalized, and 48% less likely to visit an emergency department due to a flu or flu-related sickness, the CDC found.

    In a similar trend, adults overall were 44% less likely to visit an emergency department and 39% less likely to be hospitalized for a flu-related illness or complication. In comparison, adults were just 25% less likely to be hospitalized or visit emergency departments and urgent cares during the 2021-2022 season with the last vaccine.

    Researchers emphasized the effectiveness of the vaccine among people above 65 years of age and the immunocompromised population, two groups that are more likely to get a more severe illness from the flu and less likely to have an immune response to the vaccine. 

    The 2022-2023 flu virus peaked in November and early December, when the percent of positive tests hit about 26%. The percent of positive cases is now at approximately 1.7%. Influenza-related hospitalizations have also leveled.

    While the number of flu patients has gone down, the CDC noted that this season’s influenza activity was higher and more damaging than it was in the previous two seasons. In fact, there were 111 influenza-associated deaths among children.

    Source link

  • The Future of At-Home Testing: Flu, RSV Rapid Tests Are Coming

    The Future of At-Home Testing: Flu, RSV Rapid Tests Are Coming

    Feb. 2, 2023 – It’s easy these days to take an at-home COVID test when you have symptoms like a fever and sore throat. But when the test is negative, the next step toward diagnosis usually means leaving the comforts of home.

    But that could soon change. The FDA says it is confident that at-home rapid tests like those for COVID-19 are forthcoming for the flu and respiratory syncytial virus, or RSV. 

    The division of the National Institutes of Health that helped create rapid COVID tests confirmed it is partnering with developers on combination tests that can look for multiple respiratory illnesses.

    Combination tests that can look for the markers of more than one disease are called multi-analyte. Europe and Australia already have over-the-counter tests that look for flu and RSV along with COVID-19.

    “We will be authorizing at-home flu and/or RSV tests that are multi-analyte with COVID,” an FDA official told WebMD. “I can’t tell you exactly when that would happen, but we are eager to do that.”

    Making such an at-home test possible would be in line with  the FDA’s goals to expand  health care equity and affordability, the official said. 

    Right now, the process for developing and applying for FDA approval of combination tests is less complicated and  expensive for developers under special pandemic rules. Developers get extensive assistance from the National Institute of Biomedical Imaging and Bioengineering at the NIH, particularly in the area of validation studies.

    The institute has already helped develop combination tests that can be used in health care settings, says  its director, Bruce Tromberg, PhD.

    “A couple of those have form factors that look like they should be fully at-home and over-the-counter,” he says “I’m optimistic that these will ultimately meet the performance bars that the FDA has.”

    Tromberg calls the current environment for at-home testing a “paradigm shift.” His institute estimates that more than 6.5 billion COVID tests that his organization helped create have been produced.

    “We’re actually going to probably stop counting, the numbers are just so big,” he says of the now universal  COVID test.

    From Test Tubes to Disposable Ubiquity

    With millions or even billions of COVID tests used, home testing is now commonplace in American life. 

    “The public’s expectations for medical testing are clearly being shaped differently due to the convenience, privacy, and speed of obtaining these results at home, which is a good thing,” Shannon Haymond, PhD, president of the American Association for Clinical Chemistry, wrote in an email. She is also the director of clinical mass spectrometry at the Ann & Robert H. Lurie Children’s Hospital of Chicago and an associate professor of pathology at Northwestern University Feinberg School of Medicine.

    With pandemic culture propelling demand for at-home testing, many are recalling the 1970s era known as the sexual revolution, which centered on women’s autonomy over their own bodies. During that time, pregnancy testing moved from the clinical setting to the privacy of women’s homes.

    “I really liked the term from, I think it was an EPT ad, from the ’70s that it was ‘a private little revolution,’” says historian Sarah Leavitt, PhD, a former historian at the NIH whose pregnancy test timeline, “The Thin Blue Line,” is one of the NIH’s most popular historical publications. “It brings the pregnancy test into your own private sphere, you have power over it again, and it’s your story and your body, and you can tell people when you want to.”

    Fifty years ago, the thin blue line wasn’t a 15-minute wait, which is about the time it takes these days to see the result of a pregnancy test or COVID test.

    “One big difference is that, when the first at-home pregnancy test hit the market in the 1970s, testing technology was a lot less advanced than it is today,” explained Haymond. “This means that the first home pregnancy test was very complicated to perform – it involved 10 steps and equipment like test tubes, and users had to keep the test tubes in a place free from vibrations for two hours. The easy-to-use stick tests that we’re familiar with today weren’t developed until 1988.”

    Both at-home COVID and pregnancy tests drew early concern from the medical community regarding test accuracy and potential for user error.

    “In retrospect, these concerns might seem overly cautious, but this push-pull between innovation and caution is integral to ensuring that medical advancements are made with patient safety foremost in mind,” Haymond said.

    The best approach is one that leverages the benefits of home testing with the expertise available from health care providers, who can advise when to test, how to interpret results, and determine if any extra medical care is needed, she said.

    The Future of At-Home Diagnostics

    Television can be a mirror for how science finds its place in our culture, Leavitt says. 

    “I was trying to envision when COVID tests will show up as a cultural marker in television shows,” she says, noting that beyond pregnancy tests, HIV tests and paternity tests have found their way into plots. “I don’t know what the plot point would be – maybe the test that’s found in the garbage and whose test was it?”

    By the time COVID tests show up in television, the pace of technology may have already brought a new forefront for at-home testing. Haymond foresees artificial intelligence on the horizon for at-home diagnostics.

    “Of course, like almost all areas of healthcare, we in laboratory medicine are anticipating data analytics as another major area of innovation and transformation,” she said. “This involves using technology such as artificial intelligence to find patterns and trends in healthcare datasets, and then using these findings to identify vulnerable patients before they become ill, better personalize testing and treatments, and augment human workflows in clinical testing and result interpretation.”

    In the more near-term, Tromberg at the National Institute of Biomedical Imaging and Bioengineering can envision a program that would help people in rural areas – sometimes called “health care deserts” – test at home and then easily be connected to care. The institute is already helping pilot such a program involving at-home COVID testing and connection to treatment in Pennsylvania. He could see a program like that easily using at-home flu and RSV tests.

    “People clearly would like to test at home if they could,” Tromberg says. “It’s not such a stretch, given that many people are already having telemedicine visits anyway.”

    Source link

  • U.S. Sees Most Flu Hospitalizations in a Decade

    U.S. Sees Most Flu Hospitalizations in a Decade

    Editor’s note: See cold and flu activity in your location with the WebMD tracker.

    Dec. 12, 2022 – The number of Americans hospitalized because of the flu has hit the highest levels the country has seen in at least a decade, the CDC said Friday. 

    But the number of deaths and outpatient visits for flu or flu-like illnesses was down slightly from the week before, the CDC said in its weekly FluView report.

    There were almost 26,000 new hospital admissions involving laboratory-confirmed influenza over those 7 days, up by over 31% from the previous week, based on data from 5,000 hospitals in the HHS Protect system, which tracks and shares COVID-19 data. 

    The cumulative hospitalization rate for the 2022-23 season is 26.0 per 100,000 people, the highest seen at this time of year since 2010-11, the CDC said, based on data from its Influenza Hospitalization Surveillance Network, which includes hospitals in select counties in 13 states.

    At this point in the 2019-20 season, just before the COVID-19 pandemic began, the cumulative rate was 3.1 per 100,000 people, the CDC’s data shows.

    On the positive side, the proportion of outpatient visits for influenza-like illness dropped slightly to 7.2%, from 7.5% the week before. But these cases from the CDC’s Outpatient Influenza-like Illness Surveillance Network are not laboratory-confirmed, so the data could include people with the flu, COVID-19, or respiratory syncytial virus (RSV). 

    The number of confirmed flu deaths for the week of Nov. 27 to Dec. 3 also fell slightly from the last full week of November, 246 vs. 255, but the number of pediatric deaths rose from two to seven, and total deaths in children are already up to 21 for 2022-23. That’s compared to 44 that were reported during all of the 2021-22 season, the CDC said.

    “So far this season, there have been at least 13 million illnesses, 120,000 hospitalizations, and 7,300 deaths from flu,” the agency estimated.

     

    Source link

  • Hospital financial decisions play a role in the critical shortage of pediatric beds for RSV patients:

    Hospital financial decisions play a role in the critical shortage of pediatric beds for RSV patients:

    The dire shortage of pediatric hospital beds plaguing the nation this fall is a byproduct of financial decisions made by hospitals over the past decade, as they shuttered children’s wards, which often operate in the red, and expanded the number of beds available for more profitable endeavors like joint replacements and cancer care.

    To cope with the flood of young patients sickened by a sweeping convergence of nasty bugs — especially respiratory syncytial virus, influenza, and coronavirus — medical centers nationwide have deployed triage tents, delayed elective surgeries, and transferred critically ill children out of state.

    A major factor in the bed shortage is a years-long trend among hospitals of eliminating pediatric units, which tend to be less profitable than adult units, said Mark Wietecha, CEO of the Children’s Hospital Association. Hospitals optimize revenue by striving to keep their beds 100% full — and filled with patients whose conditions command generous insurance reimbursements.

    “It really has to do with dollars,” said Dr. Scott Krugman, vice chair of pediatrics at the Herman and Walter Samuelson Children’s Hospital at Sinai in Baltimore. “Hospitals rely on high-volume, high-reimbursement procedures from good payers to make money. There’s no incentive for hospitals to provide money-losing services.”

    The number of pediatric inpatient units in hospitals fell 19% from 2008 to 2018, according to a study published in 2021 in the journal Pediatrics. Just this year, hospitals have closed pediatric units in Boston and Springfield, Massachusetts; Richmond, Virginia; and Tulsa, Oklahoma.

    The current surge in dangerous respiratory illnesses among children is yet another example of how covid-19 has upended the health care system. The lockdowns and isolation that marked the first years of the pandemic left kids largely unexposed — and still vulnerable — to viruses other than covid for two winters, and doctors are now essentially treating multiple years’ worth of respiratory ailments.

    The pandemic also accelerated changes in the health care industry that have left many communities with fewer hospital beds available for children who are acutely ill, along with fewer doctors and nurses to care for them.

    When intensive care units were flooded with older covid patients in 2020, some hospitals began using children’s beds to treat adults. Many of those pediatric beds haven’t been restored, said Dr. Daniel Rauch, chair of the American Academy of Pediatrics’ committee on hospital care.

    In addition, the relentless pace of the pandemic has spurred more than 230,000 health care providers — including doctors, nurses, and physician assistants — to quit. Before the pandemic, about 10% of nurses left their jobs every year; the rate has risen to about 20%, Wietecha said. He estimates that pediatric hospitals are unable to maintain as many as 10% of their beds because of staffing shortages.

    “There is just not enough space for all the kids who need beds,” said Dr. Megan Ranney, who works in several emergency departments in Providence, Rhode Island, including Hasbro Children’s Hospital. The number of children seeking emergency care in recent weeks was 25% higher than the hospital’s previous record.

    “We have doctors who are cleaning beds so we can get children into them faster,” said Ranney, a deputy dean at Brown University’s School of Public Health.


    Respiratory “tripledemic” worries nation’s doctors

    02:52

    There’s not great money in treating kids. About 40% of U.S. children are covered by Medicaid, a joint federal-state program for low-income patients and people with disabilities. Base Medicaid rates are typically more than 20% below those paid by Medicare, the government insurance program for older adults, and are even lower when compared with private insurance. While specialty care for a range of common adult procedures, from knee and hip replacements to heart surgeries and cancer treatments, generates major profits for medical centers, hospitals complain they typically lose money on inpatient pediatric care.

    When Tufts Children’s Hospital closed 41 pediatric beds this summer, hospital officials assured residents that young patients could receive care at nearby Boston Children’s Hospital. Now, Boston Children’s is delaying some elective surgeries to make room for kids who are acutely ill.

    Rauch noted that children’s hospitals, which specialize in treating rare and serious conditions such as pediatric cancer, cystic fibrosis, and heart defects, simply aren’t designed to handle this season’s crush of kids acutely ill with respiratory bugs.

    Even before the autumn’s viral trifecta, pediatric units were straining to absorb rising numbers of young people in acute mental distress. Stories abound of children in mental crises being marooned for weeks in emergency departments while awaiting transfer to a pediatric psychiatric unit. On a good day, Ranney said, 20% of pediatric emergency room beds at Hasbro Children’s Hospital are occupied by children experiencing mental health issues.

    In hopes of adding pediatric capacity, the American Academy of Pediatrics joined the Children’s Hospital Association last month in calling on the White House to declare a national emergency due to child respiratory infections and provide additional resources to help cover the costs of care. The Biden administration has said that the flexibility hospital systems and providers have been given during the pandemic to sidestep certain staffing requirements also applies to RSV and flu.

    Doernbecher Children’s Hospital at Oregon Health & Science University has shifted to “crisis standards of care,” enabling intensive care nurses to treat more patients than they’re usually assigned. Hospitals in Atlanta, Pittsburgh, and Aurora, Colorado, meanwhile, have resorted to treating young patients in overflow tents in parking lots.

    Dr. Alex Kon, a pediatric critical care physician at Community Medical Center in Missoula, Montana, said providers there have made plans to care for older kids in the adult intensive care unit, and to divert ambulances to other facilities when necessary. With only three pediatric ICUs in the state, that means young patients may be flown as far as Seattle or Spokane, Washington, or Idaho.

    A young child is treated in a hospital bed
    A young child with RSV is treated at the Community Medical Center in Missoula, Montana. 

    Community Medical Center


    Hollis Lillard took her 1-year-old son, Calder, to an Army hospital in Northern Virginia last month after he experienced several days of fever, coughing, and labored breathing. They spent seven anguished hours in the emergency room before the hospital found an open bed and transferred them by ambulance to Walter Reed National Military Medical Center in Maryland.

    With proper therapy and instructions for home care, Calder’s virus was readily treatable: He recovered after he was given oxygen and treated with steroids, which fight inflammation, and albuterol, which counteracts bronchospasms. He was discharged the next day.

    Although hospitalizations for RSV are falling, rates remain well above the norm for this time of year. And hospitals may not get much relief.

    People can be infected with RSV more than once a year, and Krugman worries about a resurgence in the months to come. Because of the coronavirus, which competes with other viruses, “the usual seasonal pattern of viruses has gone out the window,” he said.

    Like RSV, influenza arrived early this season. Both viruses usually peak around January. Three strains of flu are circulating and have caused an estimated 8.7 million illnesses, 78,000 hospitalizations, and 4,500 deaths, according to the Centers for Disease Control and Prevention.

    Krugman doubts the health care industry will learn any quick lessons from the current crisis. “Unless there is a radical change in how we pay for pediatric hospital care,” Krugman said, “the bed shortage is only going to get worse.”

    KHN (Kaiser Health News) is a national newsroom that produces in-depth journalism about health issues. Together with Policy Analysis and Polling, KHN is one of the three major operating programs at KFF (Kaiser Family Foundation). KFF is an endowed nonprofit organization providing information on health issues to the nation.

    Source link

  • Flu Season Raged Over Thanksgiving

    Flu Season Raged Over Thanksgiving

    Editor’s note: See cold and flu activity in your location with the WebMD tracker. 

    Dec. 2, 2022 – The flu virus made the most of the Thanksgiving holiday by reaching the highest level of national activity seen since the 2017-18 influenza season, according to the CDC. 

    The biggest 1-week increase in what is becoming an unprecedented flu season had flu-like activity at 7.5% for the week of Nov. 20-26, as measured by the proportion of outpatient visits reported to the CDC that involved respiratory illness, which may also include respiratory syncytial virus (RSV) and COVID-19.

    That 7.5% is the highest level of flu-like activity recorded in the United States since early February 2018, at the peak of the 2017-18 flu season, and the highest rate recorded in November since the CDC began tracking such data in 1997. Flu-like activity reached 7.7% in October of 2009 but then dropped below 7% by the first week of November and did not rise again for the rest of that season, the CDC’s data shows.

    There are more signs of a worse flu or flu-like season this year.. The total hospitalization rate for confirmed cases of flu, 16.6 per 100,000 people, is higher than the rate seen at this point in the season during any season since 2010-2011, the CDC said.

    The high rate of hospitalizations from Nov. 20-26 is nearly double the the previous week’s numbers, the CDC noted in its weekly Fluview report.

    So far this season, the CDC estimates, “there have been at least 8.7 million illnesses, 78,000 hospitalizations, and 4,500 deaths from flu.” In 2018-19, the last full influenza season before COVID, there were 148 deaths through the first 8 weeks, based on CDC data.

    Flu-like activity at the state and territory levels, which the CDC categorizes on a scale range from 1-13 – from minimal (1-3) to very high (11-13) – puts 31 states at very high for the week, compared with 19 the week before. Only New Hampshire and the Northern Mariana Islands are in the minimal range, according to the CDC.

    Source link

  • U.S. Flu Activity Already at Mid-Season Levels

    U.S. Flu Activity Already at Mid-Season Levels

    Nov. 29, 2022 – Reports of respiratory illness continued to rise as the 2022-23 flu season maintained its early surge through mid-November, according to the CDC. 

    Nationally, 6% of all outpatient visits were because of flu or flu-like illness for the week of Nov. 13-19, up from 5.8% the previous week, the CDC’s Influenza Division said in its weekly FluView report.

    Those figures are the highest recorded in November since 2009, but the peak of the 2009-10 flu season occurred even earlier – the week of Oct. 18-24 – and the rate of flu-like illness had already dropped to just over 4.0% by Nov. 15-21 that year and continued to drop thereafter.

    Although COVID-19 and respiratory syncytial virus (RSV) are included in the data from the CDC’s Outpatient Influenza-like Illness Surveillance Network, the agency did note that “seasonal influenza activity is elevated across the country” and estimated that “there have been at least 6.2 million illnesses, 53,000 hospitalizations, and 2,900 deaths from flu” during the 2022-23 season.

    Total flu deaths include 11 reported in children as of Nov. 19, and children ages 0-4 had a higher proportion of visits for flu like-illness than other age groups.

    The agency also said the cumulative hospitalization rate of 11.3 per 100,000 population “is higher than the rate observed in [the corresponding week of] every previous season since 2010-2011.” Adults 65 years and older have the highest cumulative rate, 25.9 per 100,000, for this year, compared with 20.7 for children 0-4; 11.1 for adults 50-64; 10.3 for children 5-17; and 5.6 for adults 18-49 years old, the CDC said.

    Source link

  • Record number of parents take off work amid

    Record number of parents take off work amid

    The U.S. is facing a “tripledemic” with cases of the flu, COVID-19 and respiratory syncytial virus (RSV) rising simultaneously as winter approaches. 

    Increasing cases of the three viruses are causing a record number of parents to miss days of work in order to take care of their sick children, data from the Bureau of Labor Statistics shows

    Last month, 104,000 workers didn’t show up because they had child care issues, according to the data. 

    “We’ve seen a big spike in RSV, in flu, COVID has yet to really hit this season. And a lot of kids are getting really sick,” Dr. Celine Gounder told CBS News.

    Parents with sick kids at home must then figure out how to take care of them. 

    “If you can’t send your child to school, a lot of parents are stuck having to stay home with their child and that really takes a hit on people’s pocketbooks,” Dr. Gounder added. 

    Employees who have to physically show up for work as well as those whose employers don’t provide paid sick leave suffer the most. Numbers of parents taking time off from work to care for sick children are only expected to increase as flu season intensifies and winter weather rolls in, public health officials say. 

    “We’re getting sicker”

    Parents with no other options may end up sending their children to child care even with they’re sick. “This is very common and unfortunately what it does is it promotes more spread of the virus in the community,” Dr. Gounder said. “We’re all getting sicker.” 

    Her advice to parents and children? 

    “If you’re sick, stay home if you can afford to. That’s definitely one of the most important things. If somebody else in your child’s play group, for example, is sick, you might want to be cancelling some of those play dates,” she said.

    The pandemic has also introduced a new tool for preventing the spread of illnesses: face masks. 

    “I think we would benefit [from wearing them.] Whether people are willing to do it, I don’t know,” Dr. Gounder said. 

    And everyone who is eligible should get vaccinated against the flu and COVID-19, she added. 

    “That’s a really good solution to prevent some of these [illnesses], is to get your kid vaccinated for the flu, for COVID. You can at least prevent those two if not RSV,” Dr. Gounder said. 

    Source link